The prevention and treatment of retinal complications in diabetes;Prävention und Therapie von Netzhautkomplikationen bei Diabetes

Deutsches Arzteblatt International

Volumn 113, Issue 48, 2016, Pages 816-823

  Schorr, Susanne Gabriele ^a   Hammes, Hans Peter ^a   Müller, Ulrich Alfons ^a   Abholz, Heinz Harald ^a   Landgraf, Rüdiger ^a   Bertram, Bernd ^a  

^a Arztliches Zentrum fur Qualitat in der Medizin   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIABETES MELLITUS; DIABETIC RETINOPATHY; COMPLICATION; HUMAN; LASER COAGULATION; MACULAR EDEMA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE;

VASCULOTROPIN A;

DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; HUMANS; LASER COAGULATION; MACULAR EDEMA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 85001115584     PISSN: 18660452     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2016.0816     Document Type: Article

References (40)

1. Nordrheinische Gemeinsame Einrichtung Disease-Management-Programme, Hagen B, Altenhofen L, et al.: Qualitätssicherungsbericht 2013. Disease-Management-Programme in Nordrhein. Brustkrebs, Diabetes mellitus Typ 1/Typ 2, Koronare Herzkrankheit, Asthma/COPD. Düsseldorf: Nordrheinische Gemeinsame Einrichtung DMP 2014.
2. Hesse L, Grusser M, Hoffstadt K, Jorgens V, Hartmann P, Kroll P: Population-based study of diabetic retinopathy in Wolfsburg. Ophthalmologe 2001;98:1065-8.
3. Blum M, Kloos C, Müller N, et al.: Prevalence of diabetic retino - pathy. Check-up program of a public health insurance company in Germany 2002-2004. Ophthalmologe 2007;104:499-500, 502-4.
4. Icks A, Rathmann W, Haastert B, et al.: Quality of care and extent of complications in a population-based sample of patients with type 2 diabetes mellitus. The KORA Survey 2000. Dtsch Med Wochenschr 2006;131:73-8.
5. Huppertz E, Pieper L, Klotsche J, et al.: Diabetes mellitus in German primary care: quality of glycaemic control and subpopulations not well controlled-results of the DETECT study. Exp Clin Endocrinol Diabetes 2009;117:6-14.
6. Böhler S, Pittrow D, Pieper L, et al.: Diabetes mellitus in der primärärztlichen Versorgung: Häufigkeit von mikro- und makrovaskulären Komplikationen - Ergebnisse der DETECT Studie. 41. Jahrestagung der Deutschen Diabetes-Gesellschaft. Diabet Stoffw 2006;1(S1):1-A315.
7. Hammes HP, Kerner W, Hofer S, Kordonouri O, Raile K, Holl RW: Diabetic retinopathy in type 1 diabetes-a contemporary analysis of 8, 784 patients. Diabetologia 2011;54:1977-84.
8. Nordrheinische Gemeinsame Einrichtung Disease-Management-Programme: Qualitätssicherungsbericht 2007. Disease Management Programme in Nordrhein. Brustkrebs, Diabetes mellitus Typ 1/Typ 2, Koronare Herzkrankheit, Asthma/COPD. Düsseldorf: Nordrheinische Gemeinsame Einrichtung DMP 2008.
9. Yau JW, Rogers SL, Kawasaki R, et al.: Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012;35:556-64.
10. Bundesärztekammer (BÄK), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), Kassenärztliche Bundesvereinigung (KBV): Nationale VersorgungsLeitlinie Therapie des Typ-2-Diabetes - Langfassung, 1st edition. Version 3. http://doi.org/10.6101/AZQ/000203 (last accessed on 5 June 2014).
11. Bundesärztekammer (BÄK), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), Kassenärztliche Bundesvereinigung (KBV): Nationale VersorgungsLeitlinie Nieren - erkrankungen bei Diabetes im Erwachsenenalter - Langfassung, 1st edition, Version 5. http://doi.org/10.6101/AZQ/000126 (last accessed on 22 June 2015).
12. Girach A, Vignati L: Diabetic microvascular complications-can the presence of one predict the development of another? J Diabetes Complications 2006;20:228-37.
13. DCCT Research Group: Effect of pregnancy on microvascular complications in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. Diabetes Care 2000;23:1084-91.
14. Kaaja R, Loukovaara S: Progression of retinopathy in type 1 diabetic women during pregnancy. Curr Diabetes Rev 2007;3:85-93.
15. Rasmussen KL, Laugesen CS, Ringholm L, Vestgaard M, Damm P, Mathiesen ER: Progression of diabetic retinopathy during pregnancy in women with type 2 diabetes. Diabetologia 2010;53:1076-83.
16. Virgili G, Menchini F, Casazza G, et al.: Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy. Cochrane Database Syst Rev 2015;1:CD008081.
17. Early Treatment Diabetic Retinopathy Study Research Group (ETDRS): Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angio graphic and other retinal characteristics at baseline: ETDRS report no. 19. Early Treatment Diabetic Retinopathy Study Research Group. Arch Ophthalmol 1995;113:1144-55.
18. Bergerhoff K, Clar C, Richter B: Aspirin in diabetic retinopathy. A systematic review. Endocrinol Metab Clin North Am 2002;31:779-93.
19. American Diabetes Association (ADA): Standards of medical care in diabetes 2014. Diabetes Care 2014;37:S14-S80.
20. Canadian Diabetes Association (CDA), Advani A, Altomare F, Stockl F: Retinopathy-clinical practice guidelines 2013. Can J Diabetes 2013;37:S137-41.
21. Diabetic Retinopathy Vitrectomy Study Research Group: Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four-year results of a randomized trial: Diabetic Retinopathy Vitrectomy Study Report 5. Arch Ophthalmol 1990;108:958-64.
22. Helbig H, Kellner U, Bornfeld N, Foerster MH: Vitrektomie bei diabetischer Retinopathie: Ergebnisse, Risikofaktoren, Komplikationen. Klin Monatsbl Augenheilkd 1998;212:339-42.
23. Ostri C: Intraocular surgery in a large diabetes patient population: risk factors and surgical results. Acta Ophthalmol 2014;92 Thesis 1:1-13.
24. Early Treatment Diabetic Retinopathy Study Research Group (ETDRS): Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991;98:766-85.
25. Early Treatment Diabetic Retinopathy Study Research Group (ETDRS): Treatment techniques and clinical guidelines for photo - coagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy study report number 2. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1987;94:761-74.
26. Early Treatment Diabetic Retinopathy Study Research Group (ETDRS): Techniques for scatter and local photocoagulation treatment of diabetic retinopathy: Early Treatment Diabetic Retinopathy study report no. 3. The Early Treatment Diabetic Retinopathy Study Research Group. Int Ophthalmol Clin 1987;27:254-64.
27. Mohamed QA, Ross A, Chu CJ: Diabetic retinopathy (treatment). BMJ Clin Evid 2011; 2011. BMJ Clin Evid 2011;2011:0702.
28. Ford JA, Lois N, Royle P, Clar C, Shyangdan D, Waugh N: Current treatments in diabetic macular oedema: systematic review and meta-analysis. BMJ Open 2013;3:e002269.
29. Bundesärztekammer (BÄK), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), Kassenärztliche Bundesvereinigung (KBV): Nationale VersorgungsLeitlinie Prävention und Therapie von Netzhautkomplikationen bei Diabetes - Leitlinien-Report, 2nd edition. Version 2. http://doi.org/10.6101/AZQ/000263 (last accessed on 18 November 2015).
30. Aiello LP, Gardner TW, King GL, et al.: Diabetic retinopathy. Diabetes Care 1998;21:143-56.
31. Echouffo-Tcheugui JB, Ali MK, Roglic G, Hayward RA, Narayan KM: Screening intervals for diabetic retinopathy and incidence of visual loss: a systematic review. Diabet Med 2013;30:1272-92.
32. Taylor-Phillips S, Mistry H, Leslie R, et al.: Extending the diabetic retinopathy screening interval beyond 1 year: systematic review. Br J Ophthalmol 201;100:105-14.
33. Leese GP, Stratton IM, Land M, et al.: Progression of diabetes retinal status within community screening programs and potential im - plications for screening intervals. Diabetes Care 2015;38:488-94.
34. Porta M, Maurino M, Severini S, et al.: Clinical characteristics influence screening intervals for diabetic retinopathy. Diabetologia 2013;56:2147-52.
35. Evans JR, Michelessi M, Virgili G: Laser photocoagulation for proliferative diabetic retinopathy. Cochrane Database Syst Rev 2014;11:CD011234.
36. Virgili G, Parravano M, Menchini F, Evans JR: Anti-vascular endothelial growth factor for diabetic macular oedema. Cochrane Database Syst Rev 2014; (10): CD007419.
37. Mitchell P, Bandello F, Schmidt-Erfurth U, et al.: The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 2011;118:615-25.
38. Korobelnik JF, Do DV, Schmidt-Erfurth U, et al.: Intravitreal aflibercept for diabetic macular edema. Ophthalmology 2014;121:2247-54.
39. Diabetic Retinopathy Clinical Research Network, Elman MJ, Bressler NM, et al.: Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2011;118:609-14.
40. Diabetic Retinopathy Clinical Research Network: A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology 2008;115:Ophthalmology 2008;115:1447-59.